lauric acid

lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.

Cross Reference

Introduction

To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with lauric acid?

lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with lauric acid

MeSH term MeSH ID Detail
Hyperlipidemias D006949 73 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Albuminuria D000419 18 associated lipids
Vasculitis D014657 14 associated lipids
Atherosclerosis D050197 85 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Bird Diseases D001715 4 associated lipids
Obesity, Morbid D009767 8 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nephrosis, Lipoid D009402 2 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Vascular System Injuries D057772 2 associated lipids
Per page 10 20 50 | Total 33

PubChem Associated disorders and diseases

What pathways are associated with lauric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with lauric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with lauric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with lauric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with lauric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with lauric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with lauric acid

Download all related citations
Per page 10 20 50 100 | Total 1837
Authors Title Published Journal PubMed Link
Ogiso T et al. Enhancement effect of lauric acid on the rectal absorption of propranolol from suppository in rats. 1991 Chem. Pharm. Bull. pmid:1806286
Yamazaki M et al. The effect of fatty acids on the rectal absorption of acyclovir in rats. 1990 J. Pharm. Pharmacol. pmid:1979629
Radom J et al. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects. 1990 Biochem. J. pmid:2165389
Ogiso T and Shintani M Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. 1990 J Pharm Sci pmid:2079652
Bergman T and Postlind H Characterization of pig kidney microsomal cytochrome P-450 catalysing 25-hydroxylation of vitamin D3 and C27 steroids. 1990 Biochem. J. pmid:2169238
Sauer G et al. Systemic treatment of a human epidermoid non-small cell lung carcinoma xenograft with a xanthate compound causes extensive intratumoral necrosis. 1990 Cancer Lett. pmid:2170004
Pedersen AO et al. Thermodynamic parameters for binding of fatty acids to human serum albumin. 1990 Eur. J. Biochem. pmid:2373077
Mensink RP and Katan MB Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. 1990 N. Engl. J. Med. pmid:2374566
Hickey AJ et al. Effect of hydrophobic coating on the behavior of a hygroscopic aerosol powder in an environment of controlled temperature and relative humidity. 1990 J Pharm Sci pmid:2292762
Aoyama T et al. Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha. 1990 J. Lipid Res. pmid:2280187
Boddupalli SS et al. Fatty acid monooxygenation by cytochrome P-450BM-3. 1990 J. Biol. Chem. pmid:2407733
Brozek KA and Raetz CR Biosynthesis of lipid A in Escherichia coli. Acyl carrier protein-dependent incorporation of laurate and myristate. 1990 J. Biol. Chem. pmid:2203778
Miranda CL et al. Regiospecificity in the hydroxylation of lauric acid by rainbow trout hepatic cytochrome P450 isozymes. 1990 Biochem. Biophys. Res. Commun. pmid:2403346
Nakamura J et al. Effect of straight chain fatty acids on seizures induced by picrotoxin and pentylenetetrazole in mice. 1990 J. Pharmacobio-dyn. pmid:2341972
Menke G et al. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths. 1989 Jan-Feb Naunyn Schmiedebergs Arch. Pharmacol. pmid:2471088
Christensen E et al. Beta-oxidation of medium chain (C8-C14) fatty acids studied in isolated liver cells. 1989 Biochim. Biophys. Acta pmid:2752017
Wada M et al. Mechanism of biosynthesis of unsaturated fatty acids in Pseudomonas sp. strain E-3, a psychrotrophic bacterium. 1989 J. Bacteriol. pmid:2753856
Ryals PE et al. Lipid modification during cytodifferentiation of Tetrahymena vorax. Whole cell phospholipids and triacylglycerols of microstomal and macrostomal phenotypes. 1989 Biochim. Biophys. Acta pmid:2730920
Sharma RK et al. Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. 1989 Biochem. Pharmacol. pmid:2554928
Makowska JM et al. Species differences in the hepatic response to a potent peroxisome proliferator. 1989 Biochem. Soc. Trans. pmid:2628085
Laignelet L et al. Induction and inhibition of rat liver cytochrome(s) P-450 by an imidazole fungicide (prochloraz). 1989 Toxicology pmid:2631296
Jarabak R and Westley J The sulfur-cyanolysis sites of serum albumin: metabolite competition studies. 1989 J. Biochem. Toxicol. pmid:2634097
Leon W et al. Fatty acid composition of amastigote and trypomastigote forms of Trypanosoma cruzi. 1989 Acta Trop. pmid:2565074
Woolfrey SG et al. The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat. 1989 J. Pharm. Pharmacol. pmid:2571709
Miranda CL et al. Purification and characterization of hepatic steroid hydroxylases from untreated rainbow trout. 1989 Arch. Biochem. Biophys. pmid:2536262
Imai Y et al. Structure-function relationships of cytochrome P-450 laurate (omega-1)-hydroxylase. 1989 Drug Metab. Rev. pmid:2680391
Graham SA Cuphea: a new plant source of medium-chain fatty acids. 1989 Crit Rev Food Sci Nutr pmid:2653730
Mishima M et al. Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I. 1989 J. Pharmacobio-dyn. pmid:2656985
Morisaki H [Inhibition of neutrophil function by solvent of injectable sedatives--effects of propylene glycol, ethanol and benzyl alcohol]. 1989 Masui pmid:2614886
Kocarek TA and Feller DR Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes. 1989 Biochem. Pharmacol. pmid:2597188
Fibach E et al. Analysis of cellular heterogeneity in the response of human leukemic cells to photosensitization induced by pyrene-containing fatty acid. 1989 Leuk. Res. pmid:2559259
Yokotani N et al. Two forms of omega-hydroxylase toward prostaglandin A and laurate. cDNA cloning and their expression. 1989 J. Biol. Chem. pmid:2600085
Khodari M et al. Applications in drug analysis of carbon paste electrodes modified by fatty acids. 1989 J Pharm Biomed Anal pmid:2490534
Murai T et al. Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits. 1989 Arzneimittelforschung pmid:2510741
Adarchenko AA et al. [Antiseptic sensitivity of clinical strains of Pseudomonas aeruginosa]. 1989 Antibiot. Khimioter. pmid:2517004
Thomas H et al. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes. 1989 Biochem. Pharmacol. pmid:2500933
Uno T and Imai Y Identification of regions functioning in substrate interaction of rabbit liver cytochrome P-450 (laurate (omega-1)-hydroxylase). 1989 J. Biochem. pmid:2691506
Boiteux-Antoine AF et al. Comparative induction of drug-metabolizing enzymes by hypolipidaemic compounds. 1989 Gen. Pharmacol. pmid:2502468
Tambo F et al. Auto-oxidation of Lingula unguis and Siphonosoma cumanense hemerythrins induced by some perturbants. 1989 Biochem. Int. pmid:2764951
Thomas OR and White GF Metabolic pathway for the biodegradation of sodium dodecyl sulfate by Pseudomonas sp. C12B. 1989 Biotechnol. Appl. Biochem. pmid:2503014
Sharma RK et al. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. 1989 Eur. J. Biochem. pmid:2776771
Green PG et al. Enhanced in vitro skin permeation of cationic drugs. 1989 Pharm. Res. pmid:2798314
Ohhira S and Matsui H [Determination of dibutyltin compounds in polyvinyl chloride resin by capillary gas chromatography]. 1989 Nihon Eiseigaku Zasshi pmid:2746975
Imaoka S et al. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. 1989 Biochem. Int. pmid:2504167
Wong KL et al. Dietary cis-fatty acids that increase protein F1 phosphorylation enhance spatial memory. 1989 Brain Res. pmid:2598047
Stucki JW et al. Acylation of proteins by myristic acid in isolated mitochondria. 1989 J. Biol. Chem. pmid:2703494
Bugaut M In vivo incorporation of lauric acid into rat adipose tissue triacylglycerols. 1989 Lipids pmid:2761351
Leakey JE et al. Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. I: The cytochrome P-450 dependent monooxygenase system. 1989 Mech. Ageing Dev. pmid:2661932
Sanglard D and Loper JC Characterization of the alkane-inducible cytochrome P450 (P450alk) gene from the yeast Candida tropicalis: identification of a new P450 gene family. 1989 Gene pmid:2663647
Frolov AF et al. Fatty acid composition of lipopolysaccharides of the strains of different species of Yersinia. 1989 J Hyg Epidemiol Microbiol Immunol pmid:2723424